Interliant, Inc. (INIT) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Interliant, Inc. (INIT)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DD™ who wrote ()	2/16/2000 2:49:00 PM
From: AlienTech	of 1214

Updated: 16-Feb-00 14:00 -- 15:00 ET (Updated throughout the hour)****** Everest Reinsurance Holdings (RE) 23 9/16 +1 1/8: J.P. Morgan upgrades from MARKET PERFORMER to BUY with a $35 price target saying improving conditions in reinsurance market should enable RE to produce double-digit revenue and earnings growth in 2000. Celgene Corporation (CELG) 139 3/4 +26: J.P. Morgan initiates coverage on biopharmaceutical company with a BUY rating; CELG's Thalomid appears to be breakthrough cancer chemotherapy drug that shrinks tumors by inhibiting blood vessel growth. Interliant (INIT) 50 1/2 +3 7/8: C.E. Unterberg, Towbin reiterates STRONG BUY rating as Dell (DELL 38 5/16 +7/16) indicates that INIT will be key partner in soon to come hosting initiative. EEX Corp. (EEX) 3 5/16 -3/8: Wasserstein Perella downgrades gas and oil exploration and production company from STRONG BUY to HOLD. Unify Corp. (UNFY) 24 3/8 -7/8: Needham & Co. raises price target from $38 to $41 based on increased estimates of Internet license revenue; reiterates STRONG BUY rating.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next